These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16393738)

  • 1. Cost-utility analysis of methadone maintenance treatment: a methodological approach.
    Vanagas G; Padaiga Z; Bagdonas E
    Subst Use Misuse; 2006; 41(1):87-101. PubMed ID: 16393738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cost-effectiveness of methadone maintenance.
    Barnett PG; Hui SS
    Mt Sinai J Med; 2000; 67(5-6):365-74. PubMed ID: 11064486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost and cost-effectiveness of standard methadone maintenance treatment compared to enriched 180-day methadone detoxification.
    Masson CL; Barnett PG; Sees KL; Delucchi KL; Rosen A; Wong W; Hall SM
    Addiction; 2004 Jun; 99(6):718-26. PubMed ID: 15139870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants.
    Giacomuzzi S; Kemmler G; Ertl M; Riemer Y
    Subst Use Misuse; 2006; 41(2):223-44. PubMed ID: 16393744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value for money in drug treatment: economic evaluation of prison methadone.
    Warren E; Viney R; Shearer J; Shanahan M; Wodak A; Dolan K
    Drug Alcohol Depend; 2006 Sep; 84(2):160-6. PubMed ID: 16487668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Economic efficiency of methadone maintenance and factors affecting it].
    Vanagas G; Padaiga Z; Subata E
    Medicina (Kaunas); 2004; 40(7):607-13. PubMed ID: 15252223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-utility analysis of methadone maintenance treatment in Lithuania.
    Vanagas G; Padaiga Z; Bagdonas E
    Medicina (Kaunas); 2010; 46(4):286-92. PubMed ID: 20571298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
    Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subsidising patient dispensing fees: the cost of injecting equity into the opioid pharmacotherapy maintenance system.
    Chalmers J; Ritter A
    Drug Alcohol Rev; 2012 Nov; 31(7):911-7. PubMed ID: 22624529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On-site medical care in methadone maintenance: associations with health care use and expenditures.
    Gourevitch MN; Chatterji P; Deb N; Schoenbaum EE; Turner BJ
    J Subst Abuse Treat; 2007 Mar; 32(2):143-51. PubMed ID: 17306723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linking opioid-dependent hospital patients to drug treatment: Health care use and costs 6 months after randomization.
    Barnett PG; Masson CL; Sorensen JL; Wong W; Hall S
    Addiction; 2006 Dec; 101(12):1797-804. PubMed ID: 17156179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
    Fareed A; Casarella J; Amar R; Vayalapalli S; Drexler K
    J Psychiatr Pract; 2009 May; 15(3):227-34. PubMed ID: 19461397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 12-month controlled trial of methadone medical maintenance integrated into an adaptive treatment model.
    King VL; Kidorf MS; Stoller KB; Schwartz R; Kolodner K; Brooner RK
    J Subst Abuse Treat; 2006 Dec; 31(4):385-93. PubMed ID: 17084792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diacetylmorphine versus methadone for opioid addiction.
    Reece AS
    N Engl J Med; 2009 Nov; 361(22):2194-5; author reply 2195. PubMed ID: 19950413
    [No Abstract]   [Full Text] [Related]  

  • 15. Exposure to opioid maintenance treatment reduces long-term mortality.
    Gibson A; Degenhardt L; Mattick RP; Ali R; White J; O'Brien S
    Addiction; 2008 Mar; 103(3):462-8. PubMed ID: 18190664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The costs of pursuing accreditation for methadone treatment sites: results from a national study.
    Zarkin GA; Dunlap LJ; Homsi G
    Eval Rev; 2006 Apr; 30(2):119-38. PubMed ID: 16492995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of costs and utilization among buprenorphine and methadone patients.
    Barnett PG
    Addiction; 2009 Jun; 104(6):982-92. PubMed ID: 19466922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Slow-release oral morphine for maintenance treatment of opioid addicts intolerant to methadone or with inadequate withdrawal suppression.
    Kastelic A; Dubajic G; Strbad E
    Addiction; 2008 Nov; 103(11):1837-46. PubMed ID: 19032534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on the change of quality of life and its influential factors for drug abusers accepting methadone maintenance treatment].
    Zhang H; Li XL; Chen MS
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):206-7. PubMed ID: 19565892
    [No Abstract]   [Full Text] [Related]  

  • 20. [Quality of life for drug abusers accepting methadone maintenance treatment].
    Li XL; Tan HZ; Sun ZQ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 33(7):601-5. PubMed ID: 18667773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.